No-knife kidney cancer treatment: new study tests radiation as a cure for inoperable patients
NCT ID NCT07299357
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at using a high-dose, targeted radiation therapy (SBRT) to treat kidney cancer in people who are too frail or at high risk for surgery. About 53 participants will receive this non-invasive treatment, which does not require anesthesia or a hospital stay. The goal is to see if SBRT can control the tumor and become a standard option for those who cannot undergo an operation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanitas PIO X
NOT_YET_RECRUITINGMilan, Milan, 20159, Italy
-
Irccs Humanitas Research Hospital
RECRUITINGRozzano, Milan, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who needs extra therapy after kidney cancer surgery?
- Can a Two-Drug combo outsmart advanced cancers?
- Can a rapid drug switch outsmart advanced kidney cancer?
- Can a new nucleotide analogue boost cancer treatment?
- Can a blast of radiation make immunotherapy work better against kidney cancer?
- Can reprogrammed immune cells take on hard-to-treat kidney cancer?